SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-174506
Filing Date
2017-05-18
Accepted
2017-05-18 08:05:36
Documents
6
Period of Report
2017-05-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d382822d8k.htm 8-K 18116
2 EX-99.1 d382822dex991.htm EX-99.1 18549
3 EX-99.2 d382822dex992.htm EX-99.2 19502
4 GRAPHIC g382822ex99_2s1g1.jpg GRAPHIC 3589108
5 GRAPHIC g382822g0518061906513.jpg GRAPHIC 3969
6 GRAPHIC g382822sn1.jpg GRAPHIC 4264
  Complete submission text file 0001193125-17-174506.txt   5011590
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 17853502
SIC: 2834 Pharmaceutical Preparations